Navigation Links
Down Syndrome Dolls in Brazil After Child Actor's Success

A Down Syndrome child actor's runaway success in a Brazilian soap opera has inspired the production of a doll with features of the genetic disorder.//

The doll will be based on "Paginas da Vida" (Pages of Life) character Clarinha, played by young actor Joana Mocarzel.

In the soap, the five-year-old Clarinha was abandoned by her genetic family because of the syndrome. Mocarzel's charisma combined with Brazilians' craze for soaps to make it a major TV success story.

The toy will be developed by a branch of Globo TV, which broadcasts the program. According to the company, revenues from the sales of the product will be donated to an NGO that provides aid to families dealing with Down Syndrome in a hospital in Sao Paulo.

Mocarzel is the daughter of journalist and filmmaker Evaldo Mocarzel, who produced and directed documentary "Do Luto a Luta" (From Mourning to Fighting), released in Brazil last year. The film's main plot centres on the disorder.

Mocarzel said he had not allowed his daughter to participate in other types of commercial advertising since she began starring in the soap.

"I only gave permission for the doll and for her to participate in the parade of samba school Imperio Serrano," said the cautious dad, adding that the parade, which will be part of Rio de Janeiro's internationally famous carnival, will also have Down Syndrome as the theme.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Early Clue to Down Syndrome
2. Hope For Stiff-Person Syndrome
3. Restless Legs Syndrome - Help at hand
4. Severe Acute respiratory Syndrome (SARS)
5. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
6. Treatment for Syndrome X
7. “ Economy Class Syndrome
8. Dementia and Down Syndrome
9. Understanding Restless Legs Syndrome
10. A New Option for Patients Suffering From QT Syndrome
11. Individuals With Metabolic Syndrome At Risk of Dying From Heart Disease
Post Your Comments:
(Date:7/3/2009)...INGTON, July 3 Republic...r language in health care reform legislation that ... this happens, many women could lose coverage for ...rently includes. Plus, millions of uninsured women...te having been promised a better quality of life. ...
(Date:7/3/2009)... Eva,s Village, ( http://www.Evas...ty Charity, Seeks Buyers for 35mm Michael Jackson ... Paterson, NJ (PRWEB) July....org ), a non-profit New Jersey anti-poverty chari... film print of Michael Jackson,s "Thriller&qu...
(Date:7/3/2009)... Two companies and three individu...ence at an annual international competition design.... The 15,000-member SafetyXChange.org community r...une 30, 2009 at http://www.safetyxchange.org/saxc... organizations who dedicate their lives to keeping...
(Date:7/3/2009)... "This is an opportunity for...taking our Diabetic Free pills, you will experienc... diabetes: your blood sugar, cholesterol levels an...will be revitalized and your mind will finally be ...life of a diabetes patient." , ...
Breaking Medicine News(10 mins):Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4
...ter chip implanted near the eye’s retina is well o... blinded by eye diseases such as Retinitis Pigment...e benefitted by the new development.// The implan...y retinal neurons remain intact after they lose us...
...ng to researchers, people with receding lower jaws...reathing. Sleep apnoea is a condition which is cha...k of the throat during sleep, impeding the free fl... accompanied by snoring and the person actually st...
...ng to researchers, the risk of undergoing open hea...beyond seems to dropping, making the procedure saf.... Todd Rosengart, an associate professor of surger...rt surgery, if indicated, is safe and will improve...
...e aspirin for pains and to prevent heart attacks, ...immune system strong. A new study says aspirin and...a common// virus linked to potentially deadly infe...immune disorders. The presence of the microbe, ca...
Other Medicine News:Health News:Heart Surgery Is Getting Safer for the Old 2
(Date:6/29/2009)...ve Study Seeks to Assess RSV Burden in Outpatient ...mitment to Pediatric Research , , GAITHERSBUR...s to advance its commitment to pediatric research ...al prospective study designed to assess the burden...m infants 32-to-35 weeks gestational age (GA) in o...
(Date:6/29/2009)...AMPTON, England, June 29 Vantia Th...veloping novel, small molecule drugs,targeting la...ve results from,a Phase IIa clinical trial of its... The trial showed that oral VA106483 was successfu...iuretic effect in patients, as determined by,incr...
(Date:6/26/2009)..., Ill., June 26, and OSAKA, Japan, June 27, 2009 /...ed ("Takeda") today announced that Takeda Global R...wned United States (U.S.) subsidiary received on J... the U.S. Food and Drug Administration (FDA) regar...alogliptin, a selective dipeptidyl peptidase IV (D...
(Date:6/26/2009)...Opinion Recommends Approval of New Anti-TNF Therap...(TM) Autoinjector , , HORSHAM, Pa. and KENILWOR...or Ortho Biotech Inc. and Schering-Plough Corporat...tee for Medicinal Products for Human Use (CHMP) of...sitive opinion recommending the approval of SIMPON...
Breaking Medicine Technology:MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10West to Host 2008 First Quarter Conference Call 17690 1West to Host 2008 First Quarter Conference Call 17690 2deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results 4856 1deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results 4856 2Number of HIV Positive State and Federal Inmates Continues to Decline 17685 1Number of HIV Positive State and Federal Inmates Continues to Decline 17685 2Number of HIV Positive State and Federal Inmates Continues to Decline 17685 3Pharma Industry Group Favors Obama as Next President 17681 1Pharma Industry Group Favors Obama as Next President 17681 2
....--(BUSINESS WIRE)--May 17, 2007 - Results,publish...cal cancer,vaccine, GARDASIL (Quadrivalent Human P...ccine) was 100 percent effective in,preventing hig...V,types 16 and 18, two types strongly associated w... observed in women who were not,infected with HPV ...
... 17, 2007 /PRNewswire-FirstCall/ -- DURECT,Corpora...as,provided its shareholders with an update on its...investigational drug for the,treatment of Alzheime... that they have observed positive outcome trends a...CT has not,independently verified the analysis per...
Other Medicine Technology:Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32DURECT Provides an Update to the Memryte Program Under Development,by Voyager Pharmaceutical Corp 2
Large deep curve.
3 mm electrode Inserts - monopolar foot control connection.
The ARK-760A is an Auto Refractor/Keratometer with both visual acuities and subjective refinement. Electronic elevation, automatic alignment, focusing, printing, high-speed measurement, unequalled ac
Sterile perfluorocarbon for intraocular Application.
Medicine Products: